Agios and Ionis Pharmaceuticals Reveal Critical SEC Filings Impacting Investors

Cambridge, Saturday, 30 August 2025.
On 30 August 2025, Agios and Ionis Pharmaceuticals updated their SEC filings, detailing mergers and financials that could significantly affect investors’ decisions. This includes a pivotal $18.5 billion acquisition.